Clinical Research Directory

Inclusion Criteria: * Any patient that electively chooses to have a cystectomy is eligible to participate in the study. Indications for a person who may undergo a cystectomy include having a diagnosis of muscle-invasive bladder cancer (MIBC) or refractory non-muscle invasive bladder cancer (NMIBC) * Any patient that will electively choose to have a robot-assisted radical cystectomy and is able to provide consent * Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure Exclusion Criteria: * Patients with a history of myasthenia gravis * Patients with a history of QT prolongation or taking other drugs that prolong corrected QTc (QTc) should be excluded * Patients with renal dysfunction, creatinine clearance (mL/min) \< 30 * Pregnant or nursing female participants * Females who receive a fertile sex sparing robot-assisted radical cystectomy (RARC) * Unwilling or unable to follow protocol requirements * Patients who receive a prophylactic antibiotic or antibiotic for any other reason prior to discharge * Any condition which in the investigator's opinion deems the participant an unsuitable candidate to receive study drug